Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
BerGenBio
Sort By
Newest First
1 / 1
1 / 1
Collaboration
Piramal Pharma Solutions Announces Collaboration with BerGenBio on the Development of FDA Fast Track Designated Leukemia Treatment
Piramal Pharma Solutions
PR-M12-19-NI-005
Dec 05, 2019
Clinical Trials
BerGenBio Meets First Efficacy Endpoint in Phase II Trial With Selective AXL Inhibitor BGB324 (bemcentinib) in NSCLC
BerGenBio ASA
PR-M01-18-NI-035
Jan 12, 2018
Oncology
Emphasis on Aggressive Cancer Cells
Richard Godfrey
BerGenBio ASA
PTV-M06-17-BIO-009
Aug 16, 2017
